In lung cancer, IL‐4 (OMIM#147780) polymorphisms have been associated with a reduced risk of non‐small cell lung cancer (NSCLC) among the Portuguese and Chinese populations (Gomes et al., 2012; Gu, Shen, & Zhang, 2014). The gene discussed is IL4; the disease is non-small cell lung carcinoma.